Ordering
Available Variants5 mg
CHA.74500-5mg
Price
€97.24
Available – Dispatch in 14 days
25 mg
CHA.74500-25mg
Price
€417.60
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.74500-5mg | €97.24 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.74500-25mg | €417.60 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C17H13Br2N5OS |
|---|---|
| CAS Number | 315704-66-6 |
| Molecular Weight | 495.19 |
| NACRES | NA.77 |
| PubChem Substance ID | 329825677 |
| UNSPSC Code | 12352200 |
| MDL number | MFCD02110649 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
PTC-209, also known by its CAS number 315704-66-6, is a small molecule inhibitor that has been investigated for its potential therapeutic applications. This compound has been shown to exhibit inhibitory activity against certain cellular pathways, leading to its exploration as a potential treatment for various diseases. PTC-209 has been studied in preclinical models, where it has demonstrated promising results, including the ability to modulate key cellular processes and induce desired outcomes. Further research is needed to fully elucidate the mechanisms of action and potential benefits of PTC-209, as well as to assess its safety and efficacy in clinical settings. As research continues to uncover the properties and potential uses of PTC-209, it remains a compound of interest in the scientific community, with potential implications for the development of novel therapies.
